June 03, 2019
The Rosen Law Firm PA will serve as lead counsel in a proposed investor class action accusing Corbus Pharmaceutical Holdings Inc. and its officers of concealing negative results in clinical trials of its flagship drug, a Massachusetts federal judge decided Monday.
March 13, 2019
A proposed class of investors hit Corbus Pharmaceutical Holdings Inc. and two of its top executives with a securities suit in Massachusetts federal court Tuesday alleging that the company and its officers concealed negative results in clinical trials of its flagship drug.